- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous complaint about emails, training, joint MA/MSL calls and call-rate targets. No breaches for emails/training/joint calls, but breach found for unclear call/contact…
Anonymous complaint alleged pressure on reps via cycle plans and CRM logging, plus GP-PEP speaker governance issues. Breaches found for unclear call/contact…
Complaint that Lilly’s oncology handbook was out of date and misleading for omitting newer cancer medicines. Panel found publication date/disclaimer were clear…
HCP website described theiCal-D3 and Stirlescent as ‘new’. Panel found theiCal-D3 had been on market >12 months so breach of Clause 7.11;…
Anonymous oncologist alleged overly frequent contact, unannounced clinic visits, old data and failure to leave copies. Panel found allegations unproven (no supporting…
Ex-rep alleged pressure to drive Seretide-to-Flutiform switches, misleading cost-savings, data protection risks, and improper use of therapy review services/meetings. Panel found no…
Complaint alleged a patient on stage during a Tivicay-focused webinar amounted to promotion to the public and that prescribing information wasn’t one-click…
BMJ website ad for Migard (frovatriptan) used an out-of-date SPC link and omitted required prescribing information elements (incl. legal classification and cost).…
A PCT chief pharmacist challenged Takeda’s PROactive study messaging in a DHP letter for Actos/Competact. The Panel found the primary endpoint was…
A Cymbalta detail aid implied duloxetine and venlafaxine XL had equivalent efficacy based on a single head-to-head study. The Panel found the…
Lilly self-reported a meeting dinner with overseas psychiatry associations. Two attendees were spouses and not qualifying delegates. Panel found hospitality non-compliant and…
A GP alleged an Acomplia journal ad implied weight-independent effects on cardiometabolic risk factors and encouraged prescribing beyond the obesity indication. Panel…
Complaint alleged a GSK representative accessed patient data and selected patients for a diabetes clinic. Panel found no evidence of access to…
Marks & Spencer magazine feature and linked website on LARC were ruled unbalanced by favouring the IUS (only Mirena in UK), encouraging…
Amgen admitted Aranesp (POM) branded materials were briefly displayed at a National Kidney Foundation conference accessible to patients/public. Panel ruled breaches of…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.